Compliance
CMO Selection and Auditing for the Homeopathic Industry
Supply Chain Management for Homeopathy, Part 2 of 4 By Tim Clarot, Industry Consultant In part one, we introduced the concept of the supply chain as part of a…
Read MoreAre You Certain Your Homeopathic Attenuation Labeling is Correct?
By Eric Foxman, Pharm., AAHP Secretary FDA noted some concerns that homeopathic drug products may not always be labeled to clearly indicate whether homeopathic attenuations have been made using…
Read MoreSupply Chain Management for Homeopathy, Part 1 of 4
By Tim Clarot, Industry Consultant Empty shelves in supermarkets, cars selling at above list price, and a critical shortage of shipping containers are some of the visible effects of a…
Read MoreFDA’s Growing Expertise in Homeopathic Manufacturing
By George Bernstein, PhD If you have participated in AAHP Summits over the past couple of years, you are no doubt aware that FDA has raised the bar regarding…
Read MoreIntroducing a New Series on Supply Chain Management
By Mark Land, AAHP President This month, we’re kicking off a series of articles on supply chain management. Penned by Tim Clarot, who spent 20 years managing a virtual supply…
Read MoreIt’s Time to Renew FDA Drug Establishment Registrations!
By Leonard Krause, FDA Connect, Inc. If you haven’t renewed your FDA Drug Establishment Registration and certified your existing drug products, it’s not too late (or too early) to start.…
Read MoreDilution Process Validation Is Complex and Data Driven
By Mark Land, AAHP President There are more than 1,300 substances currently approved for inclusion within the Homeopathic Pharmacopoeia of the United States (HPUS). Based on discussions with homeopathic manufacturers,…
Read MoreNew FDA Report on the State of Pharmaceutical Quality Fiscal Year 2020
By Mark Land, AAHP President The US FDA’s Office of Pharmaceutical Quality published its 2020 report on the state of pharmaceutical quality on August 17, 2021. Homeopathic drug products…
Read MoreAn In-Depth Review of AAHP’s 2021 Summit
By Eric L. Foxman, Pharmacist, AAHP Secretary Having listened to the speakers at AAHP’s 2021 Summit: Implementing HPUS Guidelines for FDA Compliance, Part 2, I came away with several thoughts…
Read MoreSuccess: Implementing HPUS Guidelines for FDA Compliance, Part 2
By Mark Land, AAHP President Co-hosted by AAHP and HPCUS on June 15, the Summit: Implementing HPUS Guidelines for FDA Compliance, Part 2 was an overwhelming success from multiple perspectives.…
Read More